| |||||||||||
Supplement to: Steigbigel RT et al. Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection. N Engl J Med 2008;359:339-54.
Supplement to: Cooper DA et al. Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection. N Engl J Med 2008;359:355-65.
|
View Interactive Graphic (4 MB) |
Interactive Graphic
|
This file is in Flash format. If you do not have the latest version of Flash Player, download it at www.macromedia.com. If you still cannot view the file or have other questions, you may webmaster{at}nejm.org.
| |||||||||||
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved. |